CORD-19:932bcdd2f6c6d487386e8bf983e4874387771be1 / 13029-13407 JSONTXT

Annnotations TAB JSON ListView MergeView

{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/932bcdd2f6c6d487386e8bf983e4874387771be1","sourcedb":"CORD-19","sourceid":"932bcdd2f6c6d487386e8bf983e4874387771be1","text":"To determine whether antibodies against beta-amyloid are also effective in human patients with Alzheimer's disease (AD), we participated in the Wyeth/Elan AN-1792 Phase 2A clinical trial, and included 30 patients with mild to moderate dementia who received two subsequent doses of pre-aggregated Abeta42 and QS-21 as an adjuvant in a randomized, placebo-controlled study design.","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T93","span":{"begin":0,"end":378},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"TextSentencer_T93","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"Epistemic_Statements","denotations":[{"id":"T25","span":{"begin":0,"end":378},"obj":"Epistemic_statement"}],"attributes":[{"subj":"T25","pred":"source","obj":"Epistemic_Statements"}]},{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T93","span":{"begin":0,"end":378},"obj":"Sentence"}],"attributes":[{"subj":"T93","pred":"source","obj":"CORD-19_Custom_license_subset"}]},{"project":"CORD-19-PD-HP","denotations":[{"id":"T82203","span":{"begin":95,"end":114},"obj":"Phenotype"},{"id":"T90740","span":{"begin":116,"end":118},"obj":"Phenotype"},{"id":"T47923","span":{"begin":235,"end":243},"obj":"Phenotype"}],"attributes":[{"id":"A40302","pred":"hp_id","subj":"T82203","obj":"http://purl.obolibrary.org/obo/HP_0002511"},{"id":"A78429","pred":"hp_id","subj":"T90740","obj":"http://purl.obolibrary.org/obo/HP_0002511"},{"id":"A29707","pred":"hp_id","subj":"T47923","obj":"http://purl.obolibrary.org/obo/HP_0000726"},{"subj":"T82203","pred":"source","obj":"CORD-19-PD-HP"},{"subj":"T90740","pred":"source","obj":"CORD-19-PD-HP"},{"subj":"T47923","pred":"source","obj":"CORD-19-PD-HP"}]},{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T29500","span":{"begin":45,"end":52},"obj":"Disease"},{"id":"T40255","span":{"begin":95,"end":114},"obj":"Disease"},{"id":"T85487","span":{"begin":116,"end":118},"obj":"Disease"},{"id":"T31861","span":{"begin":235,"end":243},"obj":"Disease"},{"id":"T9052","span":{"begin":45,"end":52},"obj":"Disease"},{"id":"T21372","span":{"begin":95,"end":114},"obj":"Disease"},{"id":"T90412","span":{"begin":116,"end":118},"obj":"Disease"},{"id":"T35255","span":{"begin":235,"end":243},"obj":"Disease"}],"attributes":[{"id":"A16866","pred":"mondo_id","subj":"T29500","obj":"http://purl.obolibrary.org/obo/MONDO_0019065"},{"id":"A25315","pred":"mondo_id","subj":"T40255","obj":"http://purl.obolibrary.org/obo/MONDO_0004975"},{"id":"A7878","pred":"mondo_id","subj":"T85487","obj":"http://purl.obolibrary.org/obo/MONDO_0004975"},{"id":"A54859","pred":"mondo_id","subj":"T31861","obj":"http://purl.obolibrary.org/obo/MONDO_0001627"},{"id":"A68078","pred":"mondo_id","subj":"T9052","obj":"http://purl.obolibrary.org/obo/MONDO_0019065"},{"id":"A56962","pred":"mondo_id","subj":"T21372","obj":"http://purl.obolibrary.org/obo/MONDO_0004975"},{"id":"A57674","pred":"mondo_id","subj":"T90412","obj":"http://purl.obolibrary.org/obo/MONDO_0004975"},{"id":"A24326","pred":"mondo_id","subj":"T35255","obj":"http://purl.obolibrary.org/obo/MONDO_0001627"},{"subj":"T29500","pred":"source","obj":"CORD-19-PD-MONDO"},{"subj":"T40255","pred":"source","obj":"CORD-19-PD-MONDO"},{"subj":"T85487","pred":"source","obj":"CORD-19-PD-MONDO"},{"subj":"T31861","pred":"source","obj":"CORD-19-PD-MONDO"},{"subj":"T9052","pred":"source","obj":"CORD-19-PD-MONDO"},{"subj":"T21372","pred":"source","obj":"CORD-19-PD-MONDO"},{"subj":"T90412","pred":"source","obj":"CORD-19-PD-MONDO"},{"subj":"T35255","pred":"source","obj":"CORD-19-PD-MONDO"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#93ecdb","default":true},{"id":"Epistemic_Statements","color":"#ecc193"},{"id":"CORD-19_Custom_license_subset","color":"#a693ec"},{"id":"CORD-19-PD-HP","color":"#99ec93"},{"id":"CORD-19-PD-MONDO","color":"#ec93b3"}]}]}}